IMI2 Grant awarded to fund clinical study of imatinib in the treatment of COVID-19-associated ARDS
CAMBRIDGE, UK AND DUBLIN, IRELAND, May 13 2020 / / — Exvastat (Ireland) Ltd, a privately held biopharmaceutical company backed by Cambridge Innovation Capital, today announced the [...]